Actively Recruiting
Group Telehealth Behavioral Cough Suppression Therapy
Led by University of Montana · Updated on 2024-11-27
60
Participants Needed
1
Research Sites
45 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to investigate the effectiveness of behavioral cough suppression therapy (BCST) in managing refractory chronic cough (RCC) within a group telehealth setting. RCC is a cough that has lasted at least 8 weeks and has not resolved with standard medical treatment. BCST is a research-based treatment provided by specialty-trained speech-language pathologists (SLPs) for patients with RCC. Although the treatment works very well for a large proportion of patients in a standard one-on-one format, there are a limited number of SLPs available to provide this treatment and patients living in rural areas do not typically have access to an SLP trained in BCST. If BCST can effectively be delivered in a group telehealth model, it would significantly improve accessibility to the treatment.
CONDITIONS
Official Title
Group Telehealth Behavioral Cough Suppression Therapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- At least 18 years old
- Mostly dry cough lasting at least 8 weeks
- Evaluated and treated by at least one physician for cough
- Chest X-ray or chest CT scan related to cough with no concerning results
- Access to a computer or tablet with a camera and able to use it independently
- Reliable internet access
- Willing to keep personal information of others in the study confidential
You will not qualify if you...
- Under 18 years old
- Coughing up blood
- Current smoker of any substance
- History of smoking for 10 or more years
- Diagnosed with chronic lung conditions such as COPD, emphysema, lung cancer, idiopathic pulmonary fibrosis, chronic bronchitis, or asthma (unless no formal lung testing or treatment for asthma)
- Diagnosed currently or previously with head or neck cancer
- Difficulty swallowing
- Taking medications known to cause cough including Benzapril, Captopril, Enalapril, Fosinopril, Lisinopril, Moexipril, Perindopril, Quinapril, Ramipril, or Trandolapril
- Prior behavioral cough suppression therapy with a speech-language pathologist or respiratory therapist
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Montana
Missoula, Montana, United States, 59812
Actively Recruiting
Research Team
J
Jane E Reynolds, PhD
CONTACT
L
Laurie J Slovarp, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here